ERVW-1 and infection: In this study we have shown that in a group of HIV-1 infected individuals initiating therapy during early infection, no evidence of substantial viral evolution could be found in HIV-1 env variants derived from the peripheral blood mononuclear cells or gut-associated lymphoid tissue after 1–2 years of suppressive cART.